| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance W Roh, PL Chen, A Reuben, CN Spencer, PA Prieto, JP Miller, ... Science translational medicine 9 (379), eaah3560, 2017 | 752 | 2017 |
| Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study K Takahashi, F Wang, H Kantarjian, D Doss, K Khanna, E Thompson, ... The Lancet Oncology 18 (1), 100-111, 2017 | 351 | 2017 |
| PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy JI Hsu, T Dayaram, A Tovy, E De Braekeleer, M Jeong, F Wang, J Zhang, ... Cell stem cell 23 (5), 700-713. e6, 2018 | 314 | 2018 |
| Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics K Morita, F Wang, K Jahn, T Hu, T Tanaka, Y Sasaki, J Kuipers, S Loghavi, ... Nature communications 11 (1), 1-17, 2020 | 277 | 2020 |
| Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements F Wang, H Wang, HF Tuan, DH Nguyen, V Sun, V Keser, SJ Bowne, ... Human genetics 133 (3), 331-345, 2014 | 241 | 2014 |
| Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia K Morita, HM Kantarjian, F Wang, Y Yan, C Bueso-Ramos, K Sasaki, ... Journal of Clinical Oncology, JCO. 2017.77. 6757, 2018 | 181 | 2018 |
| Comprehensive T cell repertoire characterization of non-small cell lung cancer A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ... Nature communications 11 (1), 1-13, 2020 | 168 | 2020 |
| Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing X Wang, H Wang, V Sun, HF Tuan, V Keser, K Wang, H Ren, I Lopez, ... Journal of medical genetics 50 (10), 674-688, 2013 | 158 | 2013 |
| Mutations in REEP6 Cause Autosomal-Recessive Retinitis Pigmentosa G Arno, SA Agrawal, A Eblimit, J Bellingham, M Xu, F Wang, C Chakarova, ... The American Journal of Human Genetics 99 (6), 1305-1315, 2016 | 129 | 2016 |
| Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients. J Salvo, V Lyubasyuk, M Xu, H Wang, F Wang, D Nguyen, K Wang, H Luo, ... Investigative ophthalmology & visual science 56 (3), 1937-1946, 2015 | 115 | 2015 |
| The population genomics of rhesus macaques (Macaca mulatta) based on whole-genome sequences C Xue, M Raveendran, RA Harris, GL Fawcett, X Liu, S White, M Dahdouli, ... Genome Research 26 (12), 1651-1662, 2016 | 104 | 2016 |
| Next-generation sequencing-based molecular diagnosis of 82 retinitis pigmentosa probands from Northern Ireland L Zhao, F Wang, H Wang, Y Li, S Alexander, K Wang, CE Willoughby, ... Human genetics 134 (2), 217-230, 2015 | 103 | 2015 |
| Next-Generation Sequencing–Based Molecular Diagnosis of a Chinese Patient Cohort With Autosomal Recessive Retinitis Pigmentosa Q Fu, F Wang, H Wang, F Xu, JE Zaneveld, H Ren, V Keser, I Lopez, ... Investigative ophthalmology & visual science 54 (6), 4158, 2013 | 97 | 2013 |
| Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes K Takahashi, F Wang, K Morita, Y Yan, P Hu, P Zhao, AA Zhar, CJ Wu, ... Nature communications 9 (1), 2670, 2018 | 95 | 2018 |
| Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia? M Yilmaz, F Wang, S Loghavi, C Bueso-Ramos, C Gumbs, L Little, X Song, ... Blood cancer journal 9 (2), 1-6, 2019 | 84 | 2019 |
| Mutations in human IFT140 cause non-syndromic retinal degeneration M Xu, L Yang, F Wang, H Li, X Wang, W Wang, Z Ge, K Wang, L Zhao, ... Human genetics 134 (10), 1069-1078, 2015 | 83 | 2015 |
| NGS-based Molecular diagnosis of 105 eyeGENE® probands with Retinitis Pigmentosa Z Ge, K Bowles, K Goetz, HPN Scholl, F Wang, X Wang, S Xu, K Wang, ... Scientific reports 5, 18287, 2015 | 77 | 2015 |
| Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia L Stuani, M Sabatier, E Saland, G Cognet, N Poupin, C Bosc, FA Castelli, ... Journal of Experimental Medicine 218 (5), 2021 | 73 | 2021 |
| Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative … G Montalban-Bravo, K Takahashi, K Patel, F Wang, S Xingzhi, ... Oncotarget 9 (11), 9714, 2018 | 70 | 2018 |
| Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia F Wang, K Morita, CD DiNardo, K Furudate, T Tanaka, Y Yan, KP Patel, ... Nature communications 12 (1), 1-13, 2021 | 69 | 2021 |
Koichi TakahashiThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
